| Home | E-Submission | Sitemap | Contact Us |  
Korean Journal of Clinical Oncology > Volume 5(2); 2009 > Article
Korean J Clin Oncol. 2009;5(2): 4-16.         doi: https://doi.org/10.14216/kjco.09008
The Perioperative Management of Breast Cancer
Youn Ok Lee, Lee Su Kim
Division of Breast and Endocrine Surgery, Hallym University Sacred Heart Hospital
유방암환자의 수술 전후 관리
이연옥, 김이수
한림대학교 성심병원 유방내분비외과
Corresponding Author: Lee Su Kim ,Tel: +82-31-380-5930, Fax: +82-31-384-0208, Email: lskim0503@hallym.ac.kr
Received: November 13, 2009;  Accepted: December 11, 2009.
Share :  
Breast cancer is the most commonly diagnosed cancer for women all over the world. As the report of Korea Central Cancer Registry about cancer incidence from 2003 to 2005 by Ministry of Health and Welfare in Korea, around 35.5 of a hundred thousand women were diagnosed breast cancer in 2005, which was the second most common cancer for women in Korea. As many as women concern about safety of their breasts, and want to get screening tests for breast cancer, clinicians should prepare to make a right diagnosis and management for breast cancer. While examining a patient who visited to get breast cancer screening, history taking could be one of the most crucial step to diagnose breast cancer. In order to get information related to breast cancer during taking her/his history, clinicians should know about risk factors of breast cancer. Although most commonly used screening test for breast cancer is mammography, most of Korean breast cancer patients could need additional breast sonography due to dense breast. If any abnormal lesions during physical examination or on screening test are detected, another imaging studies, such as breast sonography or breast MRI, should be taken to describe the lesion in detail. After characterizing the lesion on imaging studies, the lesion which has possibility of malignancy should be proven pathologically by biopsies, including fine needle aspiration cytology(FNAC), core needle biopsy(CNB), vacuum-assisted large core needle biopsy, and surgica biopsies. Patients who were diagnosed with breast cancer on biopsy should be evaluated for distance metastasis of disease before treatment. Modalities of treatment for breast cancer are classified into two groups, which are loco-regional treatment and systemic adjuvant treatment. Loco-regional treatment is including surgery and radiation therapy, and systemic adjuvant treatment is including neoadjuvant chemotherapy, adjuvant chemotherapy and adjuvant endocrine therapy. As there have been many advances in breast cancer management for the last several decades, perioperative management of breast cancer is getting more complicated, so that multidisciplinary approach might be necessary. Furthermore, clinicians have to take care of emotional trauma of patients.
Keywords: breast cancer | perioperative management | risk factors | diagnosis of breast cancer | treatment of breast cancer
Editorial Office
101-3304 Brownstone Seoul, 464 Cheongpa-ro, Jung-gu, Seoul 100-717, Korea
TEL : +82-2-393-2114   FAX : +82-2-393-1649   E-mail : ksco2004@paran.com

Copyright© Korean Society of Surgical Oncology. All rights reserved.                powerd by m2community
About |  Browse Articles |  Current Issue |  For Authors and Reviewers